NCT05530096View on ClinicalTrials.gov

Telo Genomics Technology to Detect & Profile Multiple Myeloma MRD

RecruitingOBSERVATIONAL
Enrollment

70

Participants

Timeline

Start Date

May 1, 2024

Primary Completion Date

September 30, 2027

Study Completion Date

September 30, 2028

Conditions
Multiple Myeloma
Interventions
DIAGNOSTIC_TEST

Standard of care

Participants will not receive any intervention in this study. Participants will receive standard of care therapy

Trial Locations (1)

H3T 1E2

RECRUITING

Jewish General Hospital, Montreal

All Listed Sponsors
lead

Sir Mortimer B. Davis - Jewish General Hospital

OTHER